Wolfgang Miesbach: Protecting Liver Health in Bleeding Disorders
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a proud post on LinkedIn:
”World Hepatitis Day 2025 – Protecting Liver Health in Bleeding Disorders. Despite curative therapies for hepatitis B and C, people with congenital bleeding disorders (PWBD) remain at elevated risk for liver complications—including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Landmark data show that even after viral eradication, factors such as metabolic dysfunction, obesity, diabetes, and alcohol drive ongoing liver injury.
New International Guidance (EAHAD, EHC, ISTH, WFH) by La Mura et al. provides a unified, evidence-based framework to proactively monitor, prevent, and manage liver complications in PWBD:
– Universal viral hepatitis screening for all PWBD exposed to blood derivatives, including assessment for occult HBV prior to immunosuppression/gene therapy
– Routine metabolic assessment (focus on MASLD and alcohol), as non-viral liver disease now rivals viral hepatitis in this population
– Non-invasive fibrosis stratification using FIB-4 and FibroScan, reducing need for biopsies and identifying patients at risk of progression
– HCC surveillance (liver ultrasound + AFP every 6 months) for those with advanced fibrosis or cirrhosis—even post-cure
– Gene therapy safety: Comprehensive liver evaluation is essential pre- and post-AAV gene therapy; advanced liver disease remains a contraindication”
Read the full article here.
Article: ”The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia”
Journal: JTH (Journal of Thrombosis and Haemostasis)
Authors: Vincenzo La Mura, Massimo Colombo, Graham R. Foster, Paolo Angeli, Wolfgang Miesbach, Robert Klamroth, Glenn F. Pierce, Brian O’Mahony, Ming Y. Lim, Virginia Hernandez-Gea, Michael Makris, Flora Peyvandi
Stay updated on the latest scientific advancements in the field of bleeding disorders with Hemostasis Today.
-
Jul 31, 2025, 16:43Jason S Knight: Antiphospholipid Syndrome Review
-
Jul 31, 2025, 16:28William McKeown: Once or Twice Weekly Altuvoct? Insights
-
Jul 31, 2025, 16:07Thomas Reiser: Submit Your Research to JTH and RPTH
-
Jul 31, 2025, 15:56eJHaem Publication and MATRON Audit Spotlight Gaps in Pulmonary Embolism Care for Pregnant Patients
-
Jul 31, 2025, 15:50Alfadil Haroon on Inherited Platelet Disorders: Know The Basics
-
Jul 31, 2025, 16:12Samin Mohsenian Shares the Final Open Access Version: Ob/Gyn Complications and Congenital Fibrinogen Disorders
-
Jul 31, 2025, 15:45Tzu-Fei Wang: To Anticoagulate or Not To Anticoagulate—That Is The Question
-
Jul 31, 2025, 15:12Wolfgang Miesbach: Protecting Liver Health in Bleeding Disorders
-
Jul 30, 2025, 16:24Cedric Hermans Invites You to Explore Hematologie Edition 2025 Nº 04
-
Jul 30, 2025, 15:53Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders